Related Experiment Video
Updated: May 16, 2026

A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder
Published on: June 18, 2018
Executive functioning in individuals with schizophrenia and/or cocaine dependence
Irina Benaiges1, Josep Maria Serra-Grabulosa, Gemma Prat
1Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona, Spain.
Schizophrenia patients with cocaine dependence showed better executive functioning than those without, but poorer cognitive set-shifting. This suggests a potentially lower genetic vulnerability for psychosis in this dual diagnosis group.
Area of Science:
- Neurocognition
- Psychiatry
- Dual Diagnosis
Background:
- Limited understanding of neurocognition in dual diagnosis patients.
- Hypothesis: Schizophrenia (SZ) patients with substance use may have lower genetic vulnerability and better premorbid functioning.
- Previous research suggests potential differences in executive and social functioning.
Purpose of the Study:
- Assess executive functioning in SZ patients with cocaine dependence.
- Explore the impact of substance use onset age on neurocognition in this group.
Main Methods:
- 95 male patients (20-60 years) studied.
- Groups: SZ+ (SZ + cocaine, n=30), SZ- (SZ only, n=30), COC (cocaine only, n=35).
- Executive functioning and cognitive set-shifting assessed.
Main Results:
- Both SZ+ and COC groups exhibited better executive functioning than the SZ- group.
- SZ+ patients performed worse than COC patients in cognitive set-shifting.
- Age of substance use onset did not affect cognitive set-shifting performance in SZ+ patients.
Conclusions:
- Findings support the hypothesis of lower genetic vulnerability in SZ+ patients.
- Psychosis in SZ- patients may develop without additional triggers.
- Further research is required to address knowledge gaps in dual diagnosis neurocognition.
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Role of Cerebellum and Prefrontal Cortex in Memory
Psychosis: Goals of Pharmacotherapy
Drug Dependence

